Enzyme therapy for Pompe disease: from science to industrial enterprise
- 1 October 2002
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 161 (1) , S106-S111
- https://doi.org/10.1007/bf02680006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.Journal of Clinical Investigation, 1998
- Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐GlucosidaseEuropean Journal of Biochemistry, 1995
- Glycogenosis type II (acid maltase deficiency)Muscle & Nerve, 1995
- Production of pharmaceutical proteins from transgenic animalsJournal of Biotechnology, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Isolation and Partial Characterization of the Structural Gene for Human Acid Alpha GlucosidaseDNA and Cell Biology, 1991
- Sequence of the cDNA and 5′-Flanking Region for Human Acid α-Glucosidase, Detection of an Intron in the 5′ Untranslated Leader Sequence, Definition of 18-bp Polymorphisms, and Differences with Previous cDNA and Amino Acid SequencesDNA and Cell Biology, 1990
- Uptake and stability of human and bovine acid α-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patientsExperimental Cell Research, 1984
- A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblastsBiochemical and Biophysical Research Communications, 1974
- Functions of LysosomesAnnual Review of Physiology, 1966